A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer.

about

A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer.

Item

http://www.wikidata.org/entity/Q54975352

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

A Phase I clinical trial of EU ...... ly advanced pancreatic cancer.

@en

A Phase I clinical trial of EU ...... ly advanced pancreatic cancer.

@nl

type

Item

label

A Phase I clinical trial of EU ...... ly advanced pancreatic cancer.

@en

A Phase I clinical trial of EU ...... ly advanced pancreatic cancer.

@nl

prefLabel

A Phase I clinical trial of EU ...... ly advanced pancreatic cancer.

@en

A Phase I clinical trial of EU ...... ly advanced pancreatic cancer.

@nl

P1476

A Phase I clinical trial of EU ...... ly advanced pancreatic cancer.

@en

P2093

Eizaburo Ohno

http://www.w3.org/2001/XMLSchema#string

Hideki Kasuya

http://www.w3.org/2001/XMLSchema#string

Hidemi Goto

http://www.w3.org/2001/XMLSchema#string

Hiroki Kawashima

http://www.w3.org/2001/XMLSchema#string

Itzel B Villalobos

http://www.w3.org/2001/XMLSchema#string

Maki Tanaka

http://www.w3.org/2001/XMLSchema#string

Nobuto Koyama

http://www.w3.org/2001/XMLSchema#string

Takuya Ishikawa

http://www.w3.org/2001/XMLSchema#string

Toru Ichinose

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Kodera

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2016

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer.

A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer.

Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer.

Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG).

Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: a prospective, randomized phase III study of the Gruppo Oncologia dell'Italia Meridionale.

P2888

s12885-018-4453-z

P304

596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4453-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1104233397

http://www.w3.org/2001/XMLSchema#string

P698

29801474

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

phase I clinical trial

P932

5970460

http://www.w3.org/2001/XMLSchema#string